- Approval Id
- 9c35a16246739b34
- Drug Name
- CLAMOVID 625 TABLET 625 mg
- Product Name
- CLAMOVID 625 TABLET 625 mg
- Approval Number
- SIN12026P
- Approval Date
- 2002-07-17
- Registrant
- GOLDPLUS UNIVERSAL PTE LTD
- Licence Holder
- GOLDPLUS UNIVERSAL PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>Dosage and Administration</strong><br>
<em><strong>CLAMOVID 625 TABLET</strong></em><br>
<strong>Adults and Children Over 12 years old:</strong></p>
<table class="borderless-100">
<tbody>
<tr>
<td>Severe infections</td>
<td>:</td>
<td>Oral, one tablet, three times a day.</td>
</tr>
<tr>
<td>Other infections</td>
<td>:</td>
<td>Oral, one tablet, two times a day.</td>
</tr>
</tbody>
</table>
<p><em><strong>Dosage in Renal Impairment:</strong></em></p>
<table class="borderless-100">
<tbody>
<tr>
<td colspan="1" rowspan="3">Adults</td>
<td>:</td>
<td>Mild impairment (Creatinine clearance > 30ml/min):<br>
No change in dosage.</td>
</tr>
<tr>
<td>:</td>
<td>Moderate impairment (Creatinine clearance 10–30 ml/min):<br>
One tablet, 12 hourly.</td>
</tr>
<tr>
<td>:</td>
<td>Severe impairment (Creatinine clearance < 10ml/min):<br>
Not recommended.</td>
</tr>
</tbody>
</table>
<p><em><strong>Dosage in Hepatic Impairment:</strong></em><br>
Dose with caution; monitor hepatic function at regular intervals.<br>
There are, as yet, insufficient data on which to base a dosage recommendation.</p>
<p>Note: Not recommended in children of 12 years and under.</p>
<p><em><strong>CLAMOVID GRANULES</strong></em><br>
The usual recommended daily dosage is 25 mg/Kg/day in divided doses every 8 hours. In more serious infections the dosage may be increased up to 50 mg/Kg/day in divided doses every eight hours.</p>
<p>Children:</p>
<table class="borderless-100">
<tbody>
<tr>
<td>1 to 6 years (10 to 18kg)</td>
<td>:</td>
<td>Oral, 5ml (approximately 125mg of Amoxycillin and 31.25mg of Clavulanic Acid every eight hour.</td>
</tr>
<tr>
<td>7 to 12 hours (18 to 40kg)</td>
<td>:</td>
<td>Oral, 10ml (approximately 250mg of Amoxycillin and 62.5mg of Clavulanic Acid) every eight hours.</td>
</tr>
</tbody>
</table>
<p><em><strong>Duration of therapy should be appropriate to the indication and should not exceed 14 days without review.</strong></em></p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications</strong><br>
For treatment of acute otitis media, sinusitis, pneumonia, skin and soft tissue infections, urinary tract infections caused by betalactamase-producing strains of bacteria.</p>
- Contraindications
- <p><strong>Contraindications</strong></p>
<ul class="dash">
<li>Contraindicated in patients known to be hypersensitive to penicillin. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins.</li>
<li>Contraindicated in patients with a previous history of penicillin-associated jaundice/hepatic dysfunction</li>
<li>Contraindicated in patients with infectious mononucleosis</li>
</ul>
- Atc Code
- J01CR02
- Atc Item Name
- amoxicillin and beta-lactamase inhibitor
- Pharma Manufacturer Name
- GOLDPLUS UNIVERSAL PTE LTD
